Guru Ownership Trend
Guru Analysis for Neurocrine Biosciences, Inc. (NBIX)
Neurocrine Biosciences, Inc. (NBIX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 8 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.16 B.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bearish. This is evidenced by a $180.56 M net outflow during the quarter.
Recent activity highlights Manning & Napier Group who dramatically increased their stake. Conversely, Ken Fisher reduced exposure by 87.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Neurocrine Biosciences, Inc. (NBIX)
Major holders include Cliff Asness ($643.47 M), Renaissance Technologies (RenTech) ($326.33 M), Joel Greenblatt ($62.62 M). According to the latest reported data, 8 tracked investment managers collectively hold approximately 6.89 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $180.56 M, with 7 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited NBIX. The total reported sell value was $202.9 M.
Yes, 0 managers opened new positions in NBIX, and 7 increased their existing holdings. The total reported buy value was $22.35 M.
